Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCE-205 in HRS-AKI
NCT05309200Phase 2Completed
- Sponsor
- Ocelot Bio
- Start
- Apr 2022
- Primary completion
- Sep 2023
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of OCE-205 in hepatorenal syndrome (HRS), sponsored by Ocelot Bio. Started Apr 2022; status: completed.
02
Drugs
OCE-205
03
Conditions
hepatorenal syndrome (HRS)
Beyond the preview
Go deeper on NCT05309200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05309200.